Longitudinal effects of SARS-CoV-2 breakthrough infection on imprinting of neutralizing antibody responses.
Einhauser S, Asam C, Weps M, Senninger A, Peterhoff D, Bauernfeind S, Asbach B, Carnell GW, Heeney JL, Wytopil M, Fuchs A, Messmann H, Prelog M, Liese J, Jeske SD, Protzer U, Hoelscher M, Geldmacher C, Überla K, Steininger P, Wagner R; CoVaKo Study group.
Einhauser S, et al.
EBioMedicine. 2024 Nov 9;110:105438. doi: 10.1016/j.ebiom.2024.105438. Online ahead of print.
EBioMedicine. 2024.
PMID: 39522353